Tamoxifen for intraductal cancer.
| Publicado en: | Lancet Vol. 354; no. 9185; pp. 1211 - 1213 |
|---|---|
| Autores principales: | , |
| Formato: | letter research Journal Article |
| Publicado: |
Lancet
10/2/1999
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125334119&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 125334119 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 10/2/1999 vid: 354 iid: 9185 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 125334119 125334119 NLM10513742 125334119 10.1016/s0140-6736(05)75421-0 NLM10513742 125334119 ppf: 1211 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Tamoxifen for intraductal cancer. aug: au: Chan, K C Bundred, N J sug: subj: Tamoxifen Therapeutic Use Breast Neoplasms Drug Therapy Antineoplastic Agents Therapeutic Use Adenocarcinoma Drug Therapy Breast Neoplasms Radiotherapy Female Combined Modality Therapy Adenocarcinoma Surgery Neoplasm Recurrence, Local Prevention and Control Adenocarcinoma Radiotherapy Breast Neoplasms Surgery Human Risk Factors Validation Studies Comparative Studies Evaluation Research Multicenter Studies Female pubtype: Academic Journal doctype: letter research Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|